Startup Funding Tracker
Home›Companies›Healthcare›RxFunction

RxFunction, Inc.

Makes a device for people with peripheral neuropathy.

ActiveHealthcare · Medical devices
Updated Nov 9, 2026·Latest SEC filing Oct 14, 2026·Suggest an edit

About RxFunction

RxFunction is a private company based in Eden Prairie, Minnesota. It has reported $28,396,201 raised in seven offerings on Form D since August 2017. Its chief executive is Mary Anderson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 27, 2022Nov 10, 2022$5,000,000of $10.0M target1$5.0MEquityRule 506(b)Form D ↗
Jan 14, 2021Jan 29, 2021amended Jan 24, 2022$3,850,530of $4.5M target33$116KOptions, Securities on exercise, The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offering.Rule 506(b)Form D/A ↗1 earlier filing
Nov 27, 2020Dec 9, 2020amended Mar 4, 2022$5,875,000of $6.0M target2$2.9MSecurities on exercise, The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offering.Rule 506(b)Form D/A ↗2 earlier filings
Mar 27, 2019Apr 3, 2019amended Oct 14, 2026$4,014,614of $4.2M target41$97,917Options, Securities on exercise, The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offerings.Rule 506(b)Form D/A ↗8 earlier filings
Mar 29, 2018Mar 29, 2018$2,056,050of $3.5M target2$1.0MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Dec 26, 2017Dec 28, 2017amended Oct 14, 2026$7,500,007of $8.0M target48$156KOptions, Securities on exercise, The underlying offerings are complete and this amendment to the original Form Ds covers only the Common Stock issuable upon exercise of warrants sold in the underlying offerings.Rule 506(b)Form D/A ↗9 earlier filings
Aug 8, 2017Aug 11, 2017$100,000of $2.0M target1$100KEquityRule 506(b)Form D ↗
Total, seven offerings$28,396,201

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on RxFunction's Form D filed Nov 10, 2022.

MA
Mary Anderson
Chief Executive Officer and director
LinkedIn ↗
LO
Lars Oddsson
Executive officer and director
LinkedIn ↗
RR
Robert Rinek
Director
RN
KR
Kevin Roche
Director
RO

Earlier filings also listed Joseph Leach (executive officer, last listed Mar 2022) and Thomas Morizio (executive officer and director, last listed Mar 2018).

Sources

  1. SECRxFunction, Inc. Form D/A, filed Oct 17, 2025
  2. SECRxFunction, Inc. Form D/A, filed Oct 17, 2025
  3. SECRxFunction, Inc. Form D/A, filed Nov 6, 2024
  4. SECRxFunction, Inc. Form D/A, filed Nov 6, 2024
  5. SECRxFunction, Inc. Form D/A, filed Nov 15, 2023
  6. SECRxFunction, Inc. Form D/A, filed Nov 15, 2023
  7. SECRxFunction, Inc. Form D/A, filed Nov 21, 2022
  8. SECRxFunction, Inc. Form D/A, filed Nov 21, 2022
  9. SECRxFunction, Inc. Form D/A, filed Mar 10, 2022
  10. SECRxFunction, Inc. Form D/A, filed Mar 9, 2022
  11. SECRxFunction, Inc. Form D/A, filed Mar 18, 2021
  12. SECRxFunction, Inc. Form D/A, filed Mar 16, 2021
  13. SECRxFunction, Inc. filing history